Strain-specific differences in the genetic control of two closely related mycobacteria

PLoS Pathogens

Volumn 6, Issue 10, 2010, Pages

  Di Pietrantonio, Tania ^a,b   Hernandez, Carmen ^a   Girard, Manon ^a   Verville, Annie ^a   Orlova, Marianna ^a,b   Belley, Adam ^a   Behr, Marcel A ^a,b   Loredo Osti, J Concepción ^c   Schurr, Erwin ^a,b  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENETICS; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL STRAIN; BCG VACCINATION; CHROMOSOME 1; CHROMOSOME 11; CONTROLLED STUDY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOTYPE; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION SENSITIVITY; LINKAGE ANALYSIS; LUNG; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUANTITATIVE TRAIT LOCUS; RECOMBINANT CONGENIC STRAIN; SPLEEN; TISSUE SPECIFICITY; ANIMAL; BACTERIAL COUNT; C57BL MOUSE; CHROMOSOME MAP; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; INBRED STRAIN; METABOLISM; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM; PATHOGENICITY; SPECIES DIFFERENCE; SPECIES DIFFERENTIATION;

CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS;

ANIMALS; ANIMALS, INBRED STRAINS; CHROMOSOME MAPPING; COLONY COUNT, MICROBIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC LINKAGE; GENETIC SPECIATION; HOST-PATHOGEN INTERACTIONS; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; SPECIES SPECIFICITY; SPLEEN;

EID: 78449303422     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001169     Document Type: Article

References (45)

1. Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD (2004) Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol 52: 1291-1302.
2. Darwin KH, Ehrt S, Gutierrez-Ramos JC, Weich N, Nathan CF (2003) The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302: 1963-1966.
3. Tobin DM, Vary JC, Jr., Ray JP, Walsh GS, Dunstan SJ, et al. (2010) The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140: 717-730.
4. Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, et al. (2009) Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 10: 899-906.
5. Gan H, Lee J, Ren F, Chen M, Kornfeld H, et al. (2008) Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol 9: 1189-1197.
6. Chen M, Divangahi M, Gan H, Shin DS, Hong S, et al. (2008) Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med 205: 2791-2801.
7. Behr M, Schurr E, Gros P (2010) TB: screening for responses to a vile visitor. Cell 140: 615-618.
8. Gagneux S, Small PM (2007) Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7: 328-337.
9. Nicol MP, Wilkinson RJ (2008) The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg 102: 955-965.
10. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, et al. (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 2869-2873.
11. Reed MB, Pichler VK, McIntosh F, Mattia A, Fallow A, et al. (2009) Major Mycobacterium tuberculosis lineages associate with patient country of origin. J Clin Microbiol 47: 1119-1128.
12. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, et al. (2008) The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 4: e1000034.
13. Herb F, Thye T, Niemann S, Browne EN, Chinbuah MA, et al. (2008) ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet 17: 1052-1060.
14. Intemann CD, Thye T, Niemann S, Browne EN, Amanua Chinbuah M, et al. (2009) Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog 5: e1000577.
15. Behr MA, Small PM (1999) A historical and molecular phylogeny of BCG strains. Vaccine 17: 915-922.
16. Calmette A, Guérin C, Breton M (1907) Contribution à l'étude de la tuberculose expérimentale du cobaye. Ann Inst Pasteur. pp 401-416.
17. Oettinger T, Jorgensen M, Ladefoged A, Haslov K, Andersen P (1999) Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber Lung Dis 79: 243-250.
18. Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, et al. (2003) Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 187: 117-123.
19. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST (2002) Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 46: 709-717.
20. Mostowy S, Tsolaki AG, Small PM, Behr MA (2003) The in vitro evolution of BCG vaccines. Vaccine 21: 4270-4274.
21. Keller PM, Bottger EC, Sander P (2008) Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant. BMC Microbiol 8: 120.
22. Brosch R, Gordon SV, Garnier T, Eiglmeier K, Frigui W, et al. (2007) Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A 104: 5596-5601.
23. Behr MA, Schroeder BG, Brinkman JN, Slayden RA, Barry CE, 3rd (2000) A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J Bacteriol 182: 3394-3399.
24. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178: 1274-1282.
25. Salamon H, Kato-Maeda M, Small PM, Drenkow J, Gingeras TR (2000) Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data. Genome Res 10: 2044-2054.
26. Charlet D, Mostowy S, Alexander D, Sit L, Wiker HG, et al. (2005) Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Mol Microbiol 56: 1302-1313.
27. Spreadbury CL, Pallen MJ, Overton T, Behr MA, Mostowy S, et al. (2005) Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation. Microbiology 151: 547-556.
28. Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, et al. (2002) BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359: 1393-1401.
29. Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S, et al. (2009) Population Differences in Immune Responses to Bacille Calmette-Guerin Vaccination in Infancy. J Infect Dis 199: 795-800.
30. Wu B, Huang C, Garcia L, Ponce de Leon A, Osornio JS, et al. (2007) Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin. Infect Immun 75: 3658-3664.
31. Liu J, Tran V, Leung AS, Alexander DC, Zhu B (2009) BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin 5: 70-78.
32. Trunz BB, Fine P, Dye C (2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367: 1173-1180.
33. Demant P, Hart AA (1986) Recombinant congenic strains-a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24: 416-422.
34. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, et al. (2001) Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 74: 21-35.
35. Gros P, Skamene E, Forget A (1981) Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 127: 2417-2421.
36. Belley A, Alexander D, Di Pietrantonio T, Girard M, Jones J, et al. (2004) Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect Immun 72: 2803-2809.
37. Mouse Genome Database (MGD) at the Mouse Genome Informatics website TJL, Bar Harbor, Maine.
38. Vidal SM, Malo D, Vogan K, Skamene E, Gros P (1993) Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73: 469-485.
39. Mullerova J, Hozak P (2004) Use of recombinant congenic strains in mapping disease-modifying genes. News Physiol Sci 19: 105-109.
40. Min-Oo G, Fortin A, Tam MF, Nantel A, Stevenson MM, et al. (2003) Pyruvate kinase deficiency in mice protects against malaria. Nat Genet 35: 357-362.
41. Roy MF, Riendeau N, Bedard C, Helie P, Min-Oo G, et al. (2007) Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice. J Exp Med 204: 2949-2961.
42. Camateros P, Marino R, Fortin A, Martin JG, Skamene E, et al. (2010) Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice. Mamm Genome 21: 28-38.
43. Schurr E, Kramnik I (2008) Genetic control of host susceptibility to tuberculosis. In: Kaufmann S, Britten W, eds. Handbook of Tuberculosis. Weinheim, Germany: Wiley-VCH. pp 305-346.
44. Greenwood CM, Fujiwara TM, Boothroyd LJ, Miller MA, Frappier D, et al. (2000) Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 67: 405-416.
45. Schurr E (2007) Is susceptibility to tuberculosis acquired or inherited? J Intern Med 261: 106-111.